RNAZ

TransCode Therapeutics, Inc. Common Stock

$2.06

+0.00 (+0.00%)

Volume:

8.547K ($17.64K)

#5040 Volume #5171 Dollar Volume

Market Capitalization:

$34.88M

#4649 Market Cap

Live Price

Live Volume

Chart Volume 0

Volume 0

5 sec

TransCode Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)

Open	$2.06
Close	$2.06
Low	$2.06
Low Change	0.00 (0.00%)
High	$2.06
High Change	+0.00 (+0.00%)
Range	$0.00
Volume	1.72K
Dollar Volume	$3.54K

Regular Trading Hours

-0.12(-5.50%)

Open	$2.18
Close	$2.06
Low	$2.05
Low Change	-0.13 (-5.96%)
High	$2.18
High Change	+0.00 (+0.00%)
Range	$0.13
Volume	6.327K
Dollar Volume	$13.03K

Premarket

+0.00(+0.00%)

Open	$2.12
Close	$2.12
Low	$2.12
Low Change	0.00 (0.00%)
High	$2.12
High Change	+0.00 (+0.00%)
Range	$0.00
Volume	500
Dollar Volume	$1.06K

After Hours Yesterday

+0.00(+0.00%)

Open	$2.16
Close	$2.16
Low	$2.16
Low Change	0.00 (0.00%)
High	$2.16
High Change	+0.00 (+0.00%)
Range	$0.00
Volume	766
Dollar Volume	$1.65K

Regular Trading Hours Yesterday

-0.21(-9.25%)

Open	$2.27
Close	$2.06
Low	$2.02
Low Change	-0.25 (-11.01%)
High	$2.27
High Change	+0.00 (+0.00%)
Range	$0.25
Volume	64.511K
Dollar Volume	$132.89K

Premarket Yesterday

+0.23(+11.86%)

Open	$1.94
Close	$2.17
Low	$1.94
Low Change	0.00 (0.00%)
High	$2.20
High Change	+0.26 (+13.40%)
Range	$0.26
Volume	2.178K
Dollar Volume	$4.73K

TransCode Therapeutics News

8 months agoinvesting.com
TransCode Therapeutics stock soars after promising glioblastoma study

TransCode Therapeutics Top Trades

TransCode Therapeutics's top trade so far today returned +2.83%, while the top short trade returned -5.96%.

Unlock the exact entry and exit times, prices, durations, and more top-performing trades with Finsuba Premium. Learn more >>>

TransCode Therapeutics Moving Averages

5 Day Moving Average (SMA5)	$2.09
10 Day Moving Average (SMA10)	$2.33
20 Day Moving Average (SMA20)	$2.90
50 Day Moving Average (SMA50)	$5.16
100 Day Moving Average (SMA100)	$5.97
200 Day Moving Average (SMA200)	$7.49

TransCode Therapeutics Statistics

Average Volume (30 Days)	62.99K
P/E Ratio (Current)	-.05
EPS (Current)	-$43.73
Dividend Yield	0.00%
Free Cash Flow	-$22.61M
Cash Ratio	1.55
Current Ratio	1.97
Quick Ratio	1.97
Debt to Equity	-0.02
Enterprise Value	-$5.60M
EV to EBITDA	0.15
EV to Sales	—
Price to Book	-0.08
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	—
Return on Assets	-0.31%
Return on Equity	1.67%

TransCode Therapeutics Stock Splits

There have been 4 stock splits for TransCode Therapeutics (RNAZ). The last reverse stock split occured on May 15, 2025 and reduced the outstanding shares at a ratio of 28:1.

Date	Type	Ratio
May 15, 2025	Reverse	28:1
Dec 4, 2024	Reverse	33:1
Jan 16, 2024	Reverse	40:1
May 23, 2023	Reverse	20:1

TransCode Therapeutics Dividends

There have been no dividends for TransCode Therapeutics (RNAZ).